ArticleBMC geriatrics2025
Influenza vaccination and ischemic stroke risk reduction in elderly stroke survivors: a retrospective cohort study with negative control validation.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND AND
objectivesStroke is a leading cause of disability and mortality among older adults, with high recurrence rates. Currently, there's limited research reporting on the protective effect of influenza vaccination against recurrent stroke in elderly stroke survivors. This study aimed to evaluate the association between influenza vaccination and stroke risk in this group.
methodsA retrospective cohort study was conducted using data from the Ningbo Regional Health Information Platform. Eligible participants were adults aged ≥ 65 years with a history of stroke, registered in the platform for ≥ 1 year by December 31, 2021. Follow-up ended at stroke occurrence, death, or July 31, 2022, whichever occurred first. The primary outcome was any stroke event. Exposure was defined as influenza vaccination during the 2021-2022 season. Adjusted subdistribution hazard ratios (sHRs) and 95% confidence intervals (CIs) were estimated using Fine-Gray competing risk models. Pneumococcal vaccination was included as a negative control outcome.
resultsAmong 76,747 participants, 31,729 (41.3%) received influenza vaccination. Over 7 months, 6,323 stroke events occurred: 5,631 ischemic, 653 hemorrhagic, and 39 unspecified. After adjusting for demographics and comorbidities, influenza vaccination was associated with a reduced risk of ischemic stroke among elderly stroke survivors (particularly those whose last stroke event occurred ≥ 1 year prior) (adjusted sHR: 0.90, 95% CI: 0.85-0.95) but showed no significant association with hemorrhagic stroke risk (adjusted sHR: 0.89, 95% CI: 0.76-1.05). Additionally, influenza vaccination demonstrated significant protective effects against both cardiogenic stroke (adjusted sHR: 0.74, 95% CI: 0.63-0.86) and non-cardiogenic stroke (adjusted sHR: 0.93, 95% CI: 0.88-0.98), with a stronger protective effect observed for cardiogenic stroke.
conclusionInfluenza vaccination is associated with lower ischemic stroke risk among elderly stroke survivors, independent of cardiogenic etiology. These findings suggest a potential nonspecific preventive benefit and highlight the need for randomized trials to establish causality and inform clinical guidelines for stroke survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.